COMP <GO>
COAG vs MESO // RETURN ON INVESTED CAPITAL (ROIC)
Hemab Therapeutics Holdings Inc. (NASDAQ) VS. Mesoblast Limited (NASDAQ) • 15-METRIC TALLY: COAG 1
— MESO 1
■ METRIC PARITY
LAST: $41.18 (-0.65%) • MKT CAP: $1.94B
roic
—
LAST: $14.54 (-4.09%) • MKT CAP: $1.97B
roic
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (COAG VS. MESO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | COAG | MESO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | — | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.4 | 57.2 | +8.20 | COAG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.94B | $1.97B | -$35.9M | MESO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | COAG REV | MESO REV | COAG GROSS % | MESO GROSS % | COAG FCF | MESO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $81.8M | — | — | — | — | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
COAG // BETA —
MESO // BETA —